These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1555819)

  • 1. Substance use disorders in a sample of Canadian patients with chronic mental illness.
    Toner BB; Gillies LA; Prendergast P; Cote FH; Browne C
    Hosp Community Psychiatry; 1992 Mar; 43(3):251-4. PubMed ID: 1555819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality disorder features as predictors of symptoms five years post-treatment.
    Jansson I; Hesse M; Fridell M
    Am J Addict; 2008; 17(3):172-5. PubMed ID: 18463992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
    Karterud S; Arefjord N; Andresen NE; Pedersen G
    Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DSM-III-R diagnoses and a brief interview for substance use among state hospital patients.
    Dixon L; Dibietz E; Myers P; Conley R; Medoff D; Lehman AF
    Hosp Community Psychiatry; 1993 Aug; 44(8):748-52. PubMed ID: 8375835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-morbidity of lifetime psychiatric disorder among male alcoholic patients.
    Penick EC; Powell BJ; Nickel EJ; Bingham SF; Riesenmy KR; Read MR; Campbell J
    Alcohol Clin Exp Res; 1994 Dec; 18(6):1289-93. PubMed ID: 7695019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?
    Kranzler HR; Kadden RM; Burleson JA; Babor TF; Apter A; Rounsaville BJ
    Compr Psychiatry; 1995; 36(4):278-88. PubMed ID: 7554872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse and associated psychiatric disorder among 100 adolescents.
    Westermeyer J; Specker S; Neider J; Lingenfelter MA
    J Addict Dis; 1994; 13(1):67-89. PubMed ID: 8018741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidity in hospitalized adolescent substance abusers.
    Hovens JG; Cantwell DP; Kiriakos R
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):476-83. PubMed ID: 8005900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of substance use disorder among psychiatric inpatients with mental illness.
    Dixon L; McNary S; Lehman AF
    Am J Psychiatry; 1998 Feb; 155(2):239-43. PubMed ID: 9464204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
    Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
    Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol & drug abuse. The myth of the typical dual diagnosis patient.
    Weiss RD; Mirin SM; Frances RJ
    Hosp Community Psychiatry; 1992 Feb; 43(2):107-8. PubMed ID: 1572604
    [No Abstract]   [Full Text] [Related]  

  • 19. Subtype by comorbidity in young adult substance abusers.
    Bennett ME; McCrady BS
    J Subst Abuse; 1993; 5(4):365-78. PubMed ID: 8186671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.